Director and Chair of the Department of Dermatology, Venerology and Dermato-oncology, University of Pécs, Hungary
Professor Rolland Gyulai’s main clinical interests are immunodermatology and oncodermatology. His specialism in the field has led to him authoring over 60 scientific papers, 8 book chapters, and holding 4 patents as well as receiving several prestigious awards.
Along with his research commitments, Professor Rolland Gyulai is a member of the board of directors, and the President-elect of the Hungarian Dermatological Society, and the President of the German-Hungarian Dermatological Society (DUDG). He is also a member of the Scientific Board of the Skin Inflammation & Psoriasis International Network (SPIN), and the European Dermatology Forum (EDF).
Disclosures: Professor Rolland Gyulai has acted as an advisor for AbbVie, Bristol-Myers Squibb, Janssen-Cilag, MSD, Novartis and Roche. He has also been an investigator in clinical trials supported by Abbvie, Bristol-Myers Squibb, Galderma, Janssen-Cilag, MSD, Novartis and Roche and received lecture and consultancy fees from AbbVie, Celgene, Janssen-Cilag, MSD and Roche.